Table 3 Experimental design of the current toxicity study of GX-G3 treatment in rats and monkeys.

From: Preclinical immunogenicity testing using anti-drug antibody analysis of GX-G3, Fc-fused recombinant human granulocyte colony-stimulating factor, in rat and monkey models

Species

Group

Dose (mg/kg)

Number of animals (male/female)

Week 0, 2, and 4

Week 8

(Dosing day 1a, 14, and day 28)

(Recovery day 29)

Rats

Vehicle control

0

3/3

3/3

T1

1

3/3

3/3

T2

3

3/3

3/3

T3

10

3/3

3/3

Species

Group

Dose (mg/kg)

Week 0, 1, 3, and 4

Week 8

(Dosing day 1, 8, 22, and 29)

(Recovery day 30)

Monkeys

Vehicle control

0

3/3

2/2

T1

1

3/3

T2

3

3/3

T3

10

3/3

2/2

  1. aRat samples for 0 h on Day 1 (Week 0) collected from pre-dosing status.